The development of fatigue is still a complication among type 2 diabetics. During exercise, a person with diabetes will experience a loss of muscle generating capacity. Currently, the mechanism of action of reduced exercise tolerance is still uncertain.
Getting your butt to the gym is hard enough without wasting your time and energy believing old wives’ tales. Case in point: Lifting weights won’t turn you into Hulk Hogan, just like a few extra squats won’t make you a Kardashian. Those and more workout myths you should stop believing, right this way.
It is important for people with diabetes– even patients who use an insulin pump – to properly prepare themselves before they engage in any type of physical activity.
Too many older Americans are falling short when it comes to their diabetes care, according to a new study.
You’ve taken the first step: vowing to eat well, starting now. Many dieters are so determined to finally lose that weight that the pounds will indeed start to whittle away. The problem, though, is that many haven’t learned from their mistakes — and within a month or so, they’ve returned to their poor eating habits. […]
The new technology, developed by a team at the University of Leeds in the United Kingdom, incorporates low-powered lasers in a small device that enables continuous blood sugar monitoring. Without the need for an implant, the device may be an ideal type of technology to develop into a wearable system.
A study from the University of Alabama at Birmingham (UAB) is testing a drug to stop the body from destroying beta cells at the onset of Type 1 diabetes, and they are casting a wide net to find volunteers, according to a WIAT.com article.
Hopes are high: Headlines about “blockbuster” and “game-changer” diet drugs emerge alongside grim reports about the obesity epidemic, which affects about 36% of adults in the United States. The latest medication to join the pack is Saxenda, the name for liraglutide, which the Food and Drug Administration approved in December.
The diabetes industry comes out en force and it was exciting to see many newsworthy announcements at a conference with so much direct access to people in the D-Community. Here’s what we captured our attention the most, from both the exhibit hall floor and the presentation sessions.
Even though health officials readily admit that diabetes is an urgent public health problem, a new diabetes medicine or device usually finds itself in ninth position on the FDA docket for a pre-market clearance. To understand why requires an understanding of the history of the FDA, and its limitations.
Individuals who are diagnosed with type 1 diabetes in their later childhood are more likely to have weaker brain connectivity in middle age compared with people diagnosed at a younger age, according to a new study.
Checked out the new Apple Watch yet? One of the most exciting aspects for people with diabetes is the Dexcom G4 Share2 app you can use on the watch to view and share your glucose data results.
Diabetes can damage a number of organs, from the eyes to the kidneys and the heart. Now there’s fresh evidence that unchecked blood sugar can affect the brain as well, which may lead to drops in cognitive functions
For those diagnosed with type-2 diabetes who were looking for a reason to explore weight loss surgery as a means of controlling their diabetes or even putting it into remission, look no further than the July 1 issue of JAMA Surgery.
Locemia Solutions is developing a nasal glucagon delivery system that doesn’t require any mixing or needle jabs. The goal is to expand the field of people who might be able to help in a crisis, says Locemia CEO Claude Piché.
Want to lose abdominal fat, get smarter and live longer? New research led by USC’s Valter Longo shows that periodically adopting a diet that mimics the effects of fasting may yield a wide range of health benefits.
The American Association of Clinical Endocrinologists (AACE) is exploring the reportedly high incidences of diabetic ketoacidosis (DKA) in people taking SGLT2 inhibitors. The investigation will take place at a conference the autumn.
Damage to the nerves (the vagus nerve) of the gastrointestinal tract causes a loss of stomach and intestinal motor control. This can lead to a mismatch between when you digest food and glucose enters the blood stream and the action time of insulin.
Researchers may have developed a patch that mimics the action of the pancreas; it senses increased levels of blood glucose and consequently releases the amount of insulin necessary to bring blood glucose levels within normal range. The patch has only been tested in mice with chemically induced type 1 diabetes.
The results showed a lower dementia incidence with pioglitazone with cumulative long-term use of pioglitazone reducing the dementia risk by 47% (RR=0.53, p=0.029) when compared to non-diabetics.